Improved Survival with Inhibitory Killer Immunoglobulin Receptor (KIR) Gene Mismatches and KIR Haplotype B Donors after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation
Heather J. Symons(Johns Hopkins University), Ephraim J. Fuchs(Johns Hopkins University), Nancy D. Rossiter(Johns Hopkins University), Mary S. Leffell(Johns Hopkins University), Richard J. Jones(Sidney Kimmel Comprehensive Cancer Center), Marianna Zahurak(Bloomberg (United States))
Cited by 183
Related Papers
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
B Cells Turn Off Virgin But Not Memory T Cells
|Science|1992|570
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation
|Cancer Chemotherapy and Pharmacology|1989|406